Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05127837 · ClinicalTrials.gov registry record · NA

CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
601
Enrollment target

NCT05127837 is a NA study that has completed, run by University of Washington. The registered enrollment target is 601 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05127837, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
601 participants
Enrollment target

Study Summary

The primary objective of this grant is to develop and evaluate an Artificial Intelligence-based clinical training tool--CBTpro--to support high-quality skills training in CBT for psychosis (CBTp). CBTpro will provide a rapid means of scaling and sustaining high-quality CBTp in routine care settings across the US.

Interventions

  • BEHAVIORAL CBTpro

Trial Details

FieldValue
Enrollment Target 601 participants
Start Date 2022-06-28
Est. Completion 2024-12-09
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT05127837

The ClinicalTrials.gov registry entry for NCT05127837 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 601 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which CBTpro is the first listed.

NCT05127837 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05127837 about?

NCT05127837 is a clinical study titled "CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies". The primary objective of this grant is to develop and evaluate an Artificial Intelligence-based clinical training tool--CBTpro--to support high-quality skills training in CBT for psychosis (CBTp). CBTpro will provide a rapid means of scaling and sustaining high-quality CBTp in routine care settings ...

What is the current status of trial NCT05127837?

This trial is currently completed. It is a NA study. The enrollment target is 601 participants. The study started on 2022-06-28. Estimated completion is 2024-12-09.

What interventions are being tested in trial NCT05127837?

The interventions under investigation include: CBTpro (BEHAVIORAL).

Who is sponsoring clinical trial NCT05127837?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.